BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spechler SJ, Katzka DA, Fitzgerald RC. New Screening Techniques in Barrett’s Esophagus: Great Ideas or Great Practice? Gastroenterology 2018;154:1594-601. [DOI: 10.1053/j.gastro.2018.03.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening. Dig Dis Sci 2021;66:1572-9. [PMID: 32578042 DOI: 10.1007/s10620-020-06412-1] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Review of Gastroenterology & Hepatology 2019;13:761-9. [DOI: 10.1080/17474124.2019.1645596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sawas T, Azad N, Killcoyne S, Iyer PG, Wang KK, Fitzgerald RC, Katzka DA. Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades. Clin Gastroenterol Hepatol 2020;18:2710-2716.e1. [PMID: 31712077 DOI: 10.1016/j.cgh.2019.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Paterson AL, Gehrung M, Fitzgerald RC, O'Donovan M. Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM. Diagn Cytopathol 2020;48:253-64. [PMID: 31814330 DOI: 10.1002/dc.24354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology 2020;159:1533-7. [DOI: 10.1053/j.gastro.2020.06.089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
7 Vaughan TL, Onstad L, Dai JY. Interactive decision support for esophageal adenocarcinoma screening and surveillance. BMC Gastroenterol 2019;19:109. [PMID: 31248371 DOI: 10.1186/s12876-019-1022-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu XX, Chen RP, Chen RC, Gong HP, Wang BF, Li YL, Lin XR, Huang ZM. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis 2019;11:2990-3003. [PMID: 31463129 DOI: 10.21037/jtd.2019.07.56] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01152-6. [PMID: 34757196 DOI: 10.1016/j.cgh.2021.10.039] [Reference Citation Analysis]
10 Bolckmans R, Roriz-silva R, Mazzini GS, Altieri MS, Docimo S, Campos GM. Long-Term Implications of GERD After Sleeve Gastrectomy. Curr Surg Rep 2021;9. [DOI: 10.1007/s40137-021-00284-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shah AK, Joshi V, Hartel G, Barbour AP, Hill MM. To BE or not to BE: non-invasive screening for Barrett's esophagus, dysplasia and adenocarcinoma. Transl Gastroenterol Hepatol 2019;4:31. [PMID: 31231698 DOI: 10.21037/tgh.2019.04.08] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Loomans-Kropp HA, Richmond E. Undetected Barrett's esophagus: how do we improve early detection? Oncotarget 2021;12:2418-20. [PMID: 34853662 DOI: 10.18632/oncotarget.28005] [Reference Citation Analysis]
13 Campos GM, Mazzini GS, Altieri MS, Docimo S Jr, DeMaria EJ, Rogers AM; Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. ASMBS position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery. Surg Obes Relat Dis 2021;17:837-47. [PMID: 33875361 DOI: 10.1016/j.soard.2021.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Peters Y, Siersema PD. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment. Clin Transl Gastroenterol 2020;11:e00260. [PMID: 33105164 DOI: 10.14309/ctg.0000000000000260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Siddiki HA, Lam-himlin DM, Kahn A, Bandres MV, Burdick GE, Crowell MD, Pannala R, Ramirez FC, Vela MF, Fleischer DE. Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett’s esophagus. Gastrointestinal Endoscopy 2019;89:759-68. [DOI: 10.1016/j.gie.2018.10.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Vajravelu RK, Kolb JM, Thanawala SU, Scott FI, Han S, Singal AG, Falk GW, Katzka DA, Wani S. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00106-3. [PMID: 33549872 DOI: 10.1016/j.cgh.2021.02.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 ASGE Standards of Practice Committee, Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S; ASGE Standards of Practice Committee Chair. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019;90:335-359.e2. [PMID: 31439127 DOI: 10.1016/j.gie.2019.05.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 38.5] [Reference Citation Analysis]
19 Schoppmann SF, Kristo I, Riegler M. Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer? Transl Gastroenterol Hepatol 2018;3:101. [PMID: 30701208 DOI: 10.21037/tgh.2018.11.07] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Swart N, Maroni R, Muldrew B, Sasieni P, Fitzgerald RC, Morris S; BEST3 Consortium. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. EClinicalMedicine 2021;37:100969. [PMID: 34195582 DOI: 10.1016/j.eclinm.2021.100969] [Reference Citation Analysis]
21 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Reference Citation Analysis]
22 LaMasters T. Comment on: Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis 2021;17:854-6. [PMID: 33676873 DOI: 10.1016/j.soard.2021.01.015] [Reference Citation Analysis]
23 Konda VJA, Souza RF. Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice? Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0685-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
24 Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clin Gastroenterol Hepatol 2020;18:767-76. [PMID: 31319183 DOI: 10.1016/j.cgh.2019.07.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
25 Li D, Zhang L, Liu Y, Sun H, Onwuka JU, Zhao Z, Tian W, Xu J, Zhao Y, Xu H. Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer. Aging (Albany NY) 2019;11:11640-58. [PMID: 31834866 DOI: 10.18632/aging.102569] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]